Mansalinog, Emilyn B.
HRN: 22-26-8401 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/05/2023
IV
1.5
Q8H
S/p CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes